Acute Respiratory Failure: Clinical Trials

19 trials for Acute Respiratory Failure, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

12 completed, 2 not yet recruiting, 2 recruiting, 1 terminated. 19 Phase 2, 6 Phase 3, 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 219Completed 12, Not yet recruiting 2, Recruiting 2, Terminated 1, Unknown 1, Withdrawn 1
Phase 36Completed 4, Not yet recruiting 1, Terminated 1
Phase 12Completed 1, Not yet recruiting 1

Follow Acute Respiratory Failure: new trials by email Literature Review of Acute Respiratory Failure trials Research Report on Acute Respiratory Failure

Trials (filtered) newest first · largest first

All 19 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Early Inflammatory-Immune Stratification and Precision Glucocorticoid Intervention in Acute Respiratory Failure Induced by Community-Acquired Pneumonia
Methylprednisolone - Acute Respiratory Failure, Community-Acquired Pneumonia
Phase 1 / Phase 2Not yet recruitingQingyuan Zhan5002026-02-012026-01-22
Physiological Effects of Nebulized Salbutamol in Acute Respiratory Failure Patients on HFNC
salbutamol 2.5 mg via vibrating mesh nebulizer (VMN) - Acute Respiratory Failure, Pneumonia
Phase 2 / Phase 3Not yet recruitingUniversità degli Studi di Ferrara202025-03-012025-02-07
Infusion of Prostacyclin vs Placebo for 72-hours in Mechanically Ventilated Patients With Acute Respiratory Failure
Iloprost, Isotonic saline - Acute Respiratory Failure, Endothelial Dysfunction
Phase 2RecruitingPär Johansson4502024-04-152025-08-22
Viscoelastic Testing Guided Tissue Plasminogen Activator Treatment in Acute Respiratory Failure
Alteplase - Acute Respiratory Failure, Hypercoagulability
Phase 2RecruitingSouth West Sydney Local Health District702022-05-182024-04-17
Propofol Versus Ketamine for Rapid Sequence Intubation in Critically Ill Patients
Esketamine, Propofol - Acute Respiratory Failure
Phase 2CompletedFederal University of São Paulo2072021-10-232026-04-17
Low Dose Morphine to Relieve Dyspnea in Acute Respiratory Failure (OPIDYS)
Chlorhydrate de morphine, NaCl 0,9%, - Acute Respiratory Failure
Phase 2CompletedAssistance Publique - Hôpitaux de Paris232020-12-162022-10-25
REmimazolam Infusion in the Context of Hypnotic Shortage in the Critical Care Unit During the Pandemic of COVID-19: REHSCU Study
Remimazolam - Acute Respiratory Failure, COVID-19
Phase 2CompletedNantes University Hospital302020-11-302021-11-04
Revefenacin in Acute Respiratory Insufficiency in COPD
Revefenacin Inhalation Solution [Yupelri], Ipratropium Bromide - COPD, Acute Respiratory Failure
Phase 2CompletedUniversity of California, Los Angeles212020-11-012026-10-14
Treatment of Lung Injury From COVID-19 Infection With Intravenous Sodium Nitrite
Sodium Nitrite, Normal Saline - COVID-19, Acute Respiratory Distress Syndrome
Phase 2WithdrawnHope Pharmaceuticals2020-07-222020-09-16
Safety and Efficacy of Hyperbaric Oxygen for ARDS in Patients With COVID-19
Hyperbaric oxygen - SARS (Severe Acute Respiratory Syndrome), Cytokine Storm
Phase 2 / Phase 3TerminatedKarolinska Institutet342020-06-032023-01-09
Mavrilimumab in Severe COVID-19 Pneumonia and Hyper-inflammation (COMBAT-19)
Mavrilimumab, Placebo - Covid-19, Acute Respiratory Failure
Phase 2UnknownOspedale San Raffaele502020-05-222020-05-26
Nutrition and Exercise in Critical Illness
IV amino acids, In-bed cycle ergometry exercise - Acute Respiratory Failure
Phase 2CompletedClinical Evaluation Research Unit at Kingston General Hospital1152017-09-282025-08-27
Enteral Feeding Composition and Acute Respiratory Failure
high-protein low-carbohydrate diet with high olive oil, high-protein low-carbohydrate diet with high sunflower oil - Acute Respiratory Failure
Phase 2 / Phase 3CompletedZahra Vahdat Shariatpanahi482013-08-012016-03-22
Testing the Feasibility of Patient Controlled Sedation for Ventilated ICU Patients
Dexmedetomidine - Acute Respiratory Failure, Anxiety
Phase 1 / Phase 2CompletedUniversity of Minnesota152013-03-012018-03-13
Clinical Effect of the Association of Noninvasive Ventilation and High Flow Nasal Oxygen Therapy in Resuscitation of Patients With Acute Lung Injury (FLORALI Study)
O2 conventional, O2-HFN : high flow nasal oxygen therapy, O2-HFN/NPPV : association of high flow nasal oxygen therapy and non invasive positive pressure ventilation - Acute Lung Injury, Acute Respiratory Failure
Phase 2 / Phase 3CompletedPoitiers University Hospital3132011-03-012016-10-11
Efficacy and Safety of Dexmedetomidine During Non-Invasive Positive Pressure Ventilation
Dexmedetomidine, Placebo - Acute Respiratory Failure
Phase 2CompletedTufts Medical Center362009-03-012017-12-18
Early Mechanical Ventilation for Guillain Barré Syndrome
mechanical ventilation, physiotherapy and oxygen if needed - Guillain Barré Syndrome, Acute Respiratory Failure
Phase 2CompletedUniversity of Versailles502005-04-012016-07-20
Timing of Target Enteral Feeding in the Mechanically Ventilated Patient
trophic enteral feeds - Acute Respiratory Failure
Phase 2 / Phase 3CompletedVanderbilt University2002003-09-012013-12-17
Heparin Binding Protein in Patients With Acute Respiratory Failure Treated With GCSF (Filgrastim)
Filgrastim - Acute Respiratory Failure, Critically Ill
Phase 2 / Phase 3CompletedHelsinki University Central Hospital591996-01-012012-10-29

Narrower conditions

COVID-19 (4)  ·  Respiratory Distress Syndrome (3)  ·  Pneumonia (2)  ·  Respiratory Insufficiency (2)  ·  Acute Lung Injury (1)  ·  Anxiety Disorders (1)  ·  Community-Acquired Pneumonia (1)  ·  Critical Illness (1)  ·  Cytokine Release Syndrome (1)  ·  Dyspnea (1)  ·  Guillain-Barre Syndrome (1)  ·  Pneumonia, Viral (1)  ·  Pulmonary Disease, Chronic Obstructive (1)  ·  Sepsis (1)  ·  Severe Acute Respiratory Syndrome (1)

Broader conditions

Respiratory Tract Diseases (11)  ·  Lung Diseases (8)  ·  Infections (7)  ·  Respiratory Tract Infections (7)  ·  Pathological Conditions, Signs and Symptoms (6)  ·  Pathologic Processes (5)  ·  Pneumonia (5)  ·  Respiration Disorders (5)  ·  Coronaviridae Infections (4)  ·  Coronavirus Infections (4)  ·  Nidovirales Infections (4)  ·  RNA Virus Infections (4)  ·  Virus Diseases (4)  ·  Disease Attributes (3)  ·  Pneumonia, Viral (3)

Interventions

Dexmedetomidine (2)  ·  Albuterol (1)  ·  Amino Acids (1)  ·  Diet, High-Protein Low-Carbohydrate (1)  ·  Esketamine (1)  ·  Filgrastim (1)  ·  Hyperbaric Oxygenation (1)  ·  Iloprost (1)  ·  Injections (1)  ·  Ipratropium (1)  ·  Methylprednisolone (1)  ·  Methylprednisolone Hemisuccinate (1)  ·  Physical Therapy Modalities (1)  ·  Propofol (1)  ·  Respiration, Artificial (1)

Sponsors

Assistance Publique - Hôpitaux de Paris (1)  ·  Clinical Evaluation Research Unit at Kingston General Hospital (1)  ·  Federal University of São Paulo (1)  ·  Helsinki University Central Hospital (1)  ·  Hope Pharmaceuticals (1)  ·  Karolinska Institutet (1)  ·  Nantes University Hospital (1)  ·  Ospedale San Raffaele (1)  ·  Poitiers University Hospital (1)  ·  Pär Johansson (1)  ·  Qingyuan Zhan (1)  ·  South West Sydney Local Health District (1)  ·  Tufts Medical Center (1)  ·  University of California, Los Angeles (1)  ·  University of Minnesota (1)

Countries

United States (6)  ·  France (4)  ·  Italy (2)  ·  Australia (1)  ·  Brazil (1)  ·  Denmark (1)  ·  Finland (1)  ·  Germany (1)  ·  Iran (1)  ·  Sweden (1)

Top investigators

Anders Aneman (1)  ·  Anders Kjellberg, MD (1)  ·  Carlo Alberto Volta, Professor (1)  ·  Craig Weinert, MD (1)  ·  Dale M Needham, MD, PhD (1)  ·  Daren K Heyland, MD, MSc (1)  ·  Donald Tashkin, MD (1)  ·  Flavia R Machado, MD, PhD (1)  ·  Igor Z Barjaktarevic, MD, PhD (1)  ·  Kenny Rodriguez-Wallberg, MD, PhD (1)  ·  Kirsi-Maija Kaukonen, MD, PhD (1)  ·  Lorenzo Dagna, MD (1)

Results publications

PMID 11098963, PMID 15883741, PMID 21242788, PMID 23363492, PMID 25981908, PMID 31371287, PMID 32997260, PMID 34226219, PMID 34930871, PMID 36175968, PMID 36743674, PMID 36765421, PMID 37510965, PMID 37607815, PMID 38675226, PMID 38783367, PMID 39014448, PMID 39393522, PMID 40174701, PMID 41259542, PMID 41870554, PMID 42438140

NIH funding

2019 (1), R21NR012795 (1)